Mr. Ofer Haviv
President and Chief Executive Officer
Ofer Haviv holds the position of Evogene's President and CEO as of late 2004. Prior to that he held the positions of company COO and CFO from 2002 to 2004 and was involved in Evogene's spin-off from Compugen in 2002. At Compugen, he held the position of Director of Finance and Treasurer of Compugen (NASDAQ: CGEN) for four years, during which time the company completed two private placements and an IPO on NASDAQ
Mr. Haviv holds a B.A. degree in Economics and Accounting from Faculty of Management, Tel Aviv University and is a Certified Public Accountant in Israel.firstname.lastname@example.org
Dr. Hagai Karchi
EVP Development and CTO
Dr. Karchi is co-founder of Evogene and served as its CEO from 2002 to 2004. Prior to the spin-off of Evogene from Compugen he was the Co-Head of Compugen's Plant Genomic Division. He has over 15 years experience in the breeding of tomatoes and in molecular genomics research. His scientific achievements include the development of a molecular system for gene discovery and the development of high yielding, high quality greenhouse tomato varieties. Dr. Karchi has lectured widely in the field of plant genomics and has an extensive record of publications and patents.
Dr. Karchi holds B.Sc and M.Sc degrees from the Hebrew University of Jerusalemױs Faculty of Agriculture, specializing in gene expression. He holds a Ph.D. from The Weizmann Institute of Science and the Hebrew University of Jerusalem, Israel.email@example.com
Mr. Assaf Oron
EVP Strategy and Business Development
Assaf joined Evogene in 2006 and has since led the company's business development and strategy efforts. Prior to joining Evogene, Assaf was CEO of ChondroSite, a biotechnology company that develops tissue engineered products in the field of orthopedics. Prior to ChondroSite, Assaf worked at Glenrock, a private investment company, overseeing various biotechnology related ventures, and led several strategic consulting roles at POC, a leading Israeli management consulting firm.
Assaf holds an M.Sc. degree in Biology and a B.Sc. degree in Economics and Chemistry from Tel Aviv University.firstname.lastname@example.org
Mr. Assaf Kacen
EVP Technology Platform
Mr. Kacen leads Evogene’s Technology Platform, overseeing the company’s field and greenhouse experiments, computational genomics and data management platforms, plant research laboratories and high-throughput validation systems, all of which form the implementation layer of the company’s research and development programs. Prior to joining Evogene, Mr. Kacen held senior product management positions at Nokia Siemens Networks where he gained substantial R&D management experience leading multi-disciplinary teams across several broad scope projects.
Mr. Kacen holds an MBA from Interdisciplinary Center, Herzlia, majoring in Finance, and a B.Sc in Communication Systems Engineering from Ben-Gurion University.email@example.com
Ms. Sigal Fattal
Chief Financial Officer
Ms. Fattal has over 16 years of experience at the Financial Sector, mainly with Blue Chip International and public companies. Prior to joining Evogene, during the years 2011-2012, Ms. Fattal served as the CEO of wwCFO Ltd., prior to that during the years 2008-2010, Ms. Fattal held the position of CFO and VP Business Development of Cal International.
Ms. Fattal holds a B.A. in accounting and economics, with honors, and a MBA specializing in finance and marketing, both from Tel Aviv firstname.lastname@example.org
Dr. Eyal Emmanuel
Executive Vice President R&D, Crop Protection
Dr. Emmanuel joined Evogene in May 2006, and since that time has held various R&D management positions at the Company, most recently as Vice President R&D of the Company’s Ag-Chemicals division. Prior to joining Evogene, Dr. Emmanuel served as a researcher at Life Science Research Israel, Israel’s premier life sciences research center.Eyal.Emmanuel@evogene.com
Dr. Emmanuel holds a B.Sc. from the Hebrew University, Faculty of Agriculture and an M.Sc.and Ph.D from the Weizmann Institute of Science. Dr. Emmanuel also holds an MBA, from the College of Management in Israel, majoring in Bio-Medical Management.